OneMedNet regains Nasdaq bid price compliance after 10 days at or above $1.00
OneMedNet Corporation received written notice from Nasdaq on October 13, 2026 that it has regained compliance with the $1.00 minimum bid price requirement, closing the matter. The company had received a deficiency letter on April 14, 2026, and the closing bid price was at least $1.00 per share for 10 consecutive business days from September 29 through October 12, 2026. The filing shows the listing issue is resolved, which removes the risk of delisting over the bid price rule.
Key points
- Nasdaq notified the company on October 13, 2026 that it regained compliance with Listing Rule 5550(a)(2).
- The closing bid price was at least $1.00 per share for 10 consecutive business days, September 29 to October 12, 2026.
- The original deficiency notice was received April 14, 2026, with a grace period to October 12, 2026.
- The matter is now closed, according to the filing signed by CEO Aaron Green.
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 14, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.